Deregulation of CRAD-controlled cytoskeleton initiates mucinous colorectal cancer via β-catenin

Youn Sang Jung, Wenqi Wang, Sohee Jun, Jie Zhang, Mrinal Srivastava, Moon Jong Kim, Esther M. Lien, Joan Shang, Junjie Chen, Pierre D. McCrea, Songlin Zhang, Jae Il Park

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Abstract

Epithelial integrity is maintained by the cytoskeleton and through cell adhesion. However, it is not yet known how a deregulated cytoskeleton is associated with cancer. We identified cancer-related regulator of actin dynamics (CRAD) as frequently mutated or transcriptionally downregulated in colorectal cancer. We found that CRAD stabilizes the cadherin–catenin–actin complex via capping protein inhibition. The loss of CRAD inhibits F-actin polymerization and subsequently disrupts the cadherin–catenin–actin complex, which leads to β-catenin release and Wnt signalling hyperactivation. In mice, CRAD knockout induces epithelial cell integrity loss and Wnt signalling activation, resulting in the development of intestinal mucinous adenoma. With APC mutation, CRAD knockout initiates and accelerates mucinous and invasive adenoma development in the colorectum. These results define CRAD as a tumour suppressor, the inactivation of which deregulates the cytoskeleton and hyperactivates Wnt signalling thus initiating mucinous colorectal cancer. Our study reveals the unexpected roles of an actin cytoskeletal regulator in maintaining epithelial cell integrity and suppressing tumorigenesis.

Original languageEnglish (US)
Pages (from-to)1303-1314
Number of pages12
JournalNature cell biology
Volume20
Issue number11
DOIs
StatePublished - Nov 1 2018

ASJC Scopus subject areas

  • Cell Biology

MD Anderson CCSG core facilities

  • Advanced Technology Genomics Core
  • Genetically Engineered Mouse Facility
  • Research Animal Support Facility
  • Small Animal Imaging Facility

Fingerprint

Dive into the research topics of 'Deregulation of CRAD-controlled cytoskeleton initiates mucinous colorectal cancer via β-catenin'. Together they form a unique fingerprint.

Cite this